Millions of Americans who are prescribed statins never fill the prescription. The reasons are familiar: fear of side effects, a preference for lifestyle changes, or a general reluctance to take daily medication. However, this hesitation is creating a dangerous “treatment gap.”
Experts warn that this avoidance is not merely a personal choice with minor consequences; it is a public health issue. By skipping these cholesterol-lowering drugs, tens of thousands of people may be exposing themselves to preventable heart attacks, strokes, and emergency surgeries every year.
For those at risk of cardiovascular disease, understanding the nuanced benefits and risks of statins is no longer optional—it is essential for survival.
What Statins Actually Do
Statins are widely recognized for lowering low-density lipoprotein (LDL), or “bad” cholesterol. But their role in heart health goes far beyond simple number-crunching. These medications work by inhibiting cholesterol production in the liver, but their true value lies in how they interact with the arterial system.
“Statins stabilize plaque in the arteries so it is less likely to rupture, they reduce inflammation in blood vessels, and they improve overall blood flow and vessel function,” explains Sadeer Al-Kindi, MD, a preventive cardiologist at Houston Methodist.
This stabilization is critical. A heart attack often occurs not because an artery is completely blocked, but because a plaque ruptures and triggers a clot. Statins make that plaque less likely to burst. Consequently, even individuals with moderate cholesterol levels can benefit significantly from statin therapy in preventing acute cardiac events.
Who Should Take Statins?
Not everyone needs a statin, but the criteria for who does have become more precise. The American College of Cardiology (ACC) and American Heart Association (AHA) recently updated their guidelines for managing dyslipidemia (abnormal cholesterol/triglyceride levels). The recommendations are tiered based on risk intensity:
- Primary Prevention: Individuals without known heart disease may still qualify if risk assessment tools predict a high probability of a future heart attack or stroke.
- High Cholesterol: Statins are the primary treatment for LDL levels of 190 mg/dL or higher, or triglycerides at 150 mg/dL or higher.
- Chronic Disease: Adults aged 40–75 with diabetes, chronic kidney disease (stage 3+), or HIV are typically prescribed moderate-intensity statins.
- Established Cardiovascular Disease: Patients with existing atherosclerotic cardiovascular disease (ASCVD) are recommended high-intensity statins.
- Subclinical Atherosclerosis: Those with detected plaque buildup but no symptoms are also candidates, with dosage adjusted based on the severity of calcium buildup.
Beyond LDL: The New Diagnostic Toolkit
Relying solely on LDL cholesterol is an outdated strategy. Modern cardiology is shifting toward a more comprehensive view of heart health, utilizing advanced biomarkers to identify risk that traditional tests miss.
1. Coronary Artery Calcium (CAC) Scoring
This CT scan detects early plaque buildup in the arteries. A high CAC score places a patient in the same risk category as someone with established heart disease, often prompting intensified statin therapy even if cholesterol numbers look acceptable.
2. Apolipoprotein B (ApoB)
ApoB is a protein found on the surface of cholesterol-carrying particles. Because it provides a more detailed count of atherogenic particles, a high ApoB measurement can signal a need for statins that an LDL test might overlook.
3. Lipoprotein(a) or Lp(a)
Lp(a) is a genetically determined particle that is significantly more artery-clogging than standard LDL. While statins do not lower Lp(a) levels, they are crucial for mitigating the overall risk caused by high Lp(a).
The PREVENT Calculator: Personalizing Risk
For those without obvious risk factors, the American Heart Association’s PREVENT calculator offers a sophisticated way to estimate 10-year risk. Based on data from over 6.5 million U.S. adults, this tool considers a wide array of variables beyond just cholesterol:
- Age, sex, and race/ethnicity
- Blood pressure and BMI
- Kidney function (eGFR) and urine albumin-to-creatinine ratio
- Smoking status and history of diabetes
- Zip code: Recognizing that socioeconomic factors and community resources impact health outcomes.
A higher score, combined with family history or chronic inflammatory conditions, helps doctors determine if statin therapy is the right move.
Addressing the Diabetes Concern
A common hesitation among patients with diabetes or prediabetes is the fear that statins will worsen blood sugar control. It is true that statins can cause a small increase in blood glucose. However, this effect is generally minor.
“That’s not enough to cause diabetes in someone with normal blood glucose,” notes Michael Miller, MD, a cardiologist at Penn Medicine.
While statins might nudge a patient with prediabetes toward a diabetes diagnosis slightly sooner, the consensus among experts is clear: the cardiovascular benefits far outweigh the metabolic downsides. For diabetics, who are twice as likely to develop heart disease or stroke, statins are a vital protective measure.
The Bottom Line
The narrative around statins is shifting from “lowering cholesterol” to “preventing catastrophic events.” While concerns about side effects are valid, research indicates that serious adverse effects are rare and often overstated.
For the majority of patients—particularly those with high risk, existing disease, or diabetes—the evidence is robust: statins save lives. Ignoring these prescriptions in favor of lifestyle changes alone may leave critical vulnerabilities unaddressed. The goal is not just to feel healthy today, but to ensure the arteries remain stable and functional for years to come.
